Molecular Biology Reagents

Building blocks for novel chiral crown ethers。Application(3S,4S)-(+)-1-Benzyl-3,4-pyrrolidinediol can be used:As a building block for the preparation of novel chiral crown ethers；As an intermediate in the synthesis of

Building blocks for novel chiral crown ethers。Application(3S,4S)-(+)-1-Benzyl-3,4-pyrrolidinediol can be used:As a building block for the preparation of novel chiral crown ethers；As an intermediate in the synthesis of

Building blocks for novel chiral crown ethers。Application(3S,4S)-(+)-1-Benzyl-3,4-pyrrolidinediol can be used:As a building block for the preparation of novel chiral crown ethers；As an intermediate in the synthesis of

(3S,4S)-4-aminooxan-3-ol hydrochloride.

Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.

Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.

Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.

(3S,5R)-5-(HYdroxymethyl)pyrrolidin-3-ol hydrochloride.

(3S,5R)-5-(HYdroxymethyl)pyrrolidin-3-ol hydrochloride.

(3S,5R)-5-(HYdroxymethyl)pyrrolidin-3-ol hydrochloride.

(4-(4-CHLORO-3-METHYL-BENZOYL)-PHENYL)-(4-CHLORO-3-METHYL-PHENYL)-METHANONE-

(4-(Chloromethyl)phenyl)(trifluoromethyl)sulfane.